Showing results (181-190 of 406) with videos related to

Sort By:
Pageof 41
EULAR Rheumatology Open|June 29, 2026
Comparison of the PK, PD, safety, tolerability, and immunogenicity of proposed biosimilar RGB-19 and tocilizumab in healthy Japanese males: a phase 1, randomised, crossover studyTomoko Hasunuma, Paul Emery, Ernest Choy, et al.
The Lancet. Rheumatology|June 26, 2025
Disease-associated brain activation predicts clinical response to TNF inhibition in rheumatoid arthritis (PreCePra): a randomised, multicentre, double-blind, placebo-controlled phase 3 studyAndreas Hess, Koray Tascilar, Hanna M Schenker, et al.
Annals of the Rheumatic Diseases|March 6, 2012
Inflammation assessment in patients with arthritis using a novel in vivo fluorescence optical imaging technologyStephanie G Werner, Hans-Eckhard Langer, Sarah Ohrndorf, et al.
Annals of the Rheumatic Diseases|November 19, 2016
Efficacy and safety of sarilumab monotherapy versus adalimumab monotherapy for the treatment of patients with active rheumatoid arthritis (MONARCH): a randomised, double-blind, parallel-group phase III trialGerd R Burmester, Yong Lin, Rahul Patel, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 19, 2016
Sarilumab and Nonbiologic Disease-Modifying Antirheumatic Drugs in Patients With Active Rheumatoid Arthritis and Inadequate Response or Intolerance to Tumor Necrosis Factor InhibitorsRoy Fleischmann, Janet van Adelsberg, Yong Lin, et al.
Arthritis Research & Therapy|October 2, 2025
Real-world sex differences in treatment persistence and reasons for discontinuation in psoriatic arthritis patients: results from the German RABBIT-SpA registerLisa Lindner, Anja Weiß, Andreas Reich, et al.
BMC Musculoskeletal Disorders|November 22, 2020
Achilles tendon enthesitis evaluated by MRI assessments in patients with axial spondyloarthritis and psoriatic arthritis: a report of the methodology of the ACHILLES trialXenofon Baraliakos, Philipp Sewerin, Eugenio de Miguel, et al.
Rheumatology (Oxford, England)|April 20, 2023
The role of antidrug antibodies in ustekinumab therapy and the impact of methotrexateSorwe Mojtahed Poor, Marina Henke, Thomas Ulshöfer, et al.
Dermatology (Basel, Switzerland)|January 31, 2015
Association between skin and joint involvement in patients with psoriatic arthritis treated with adalimumab: analysis of data from a German non-interventional studyDiamant Thaçi, Frank Behrens, Gerd Greger, et al.
Rheumatology (Oxford, England)|June 23, 2016
Anti-citrullinated protein antibodies are linked to erosive disease in an observational study of patients with psoriatic arthritisFrank Behrens, Michaela Koehm, Diamant Thaçi, et al.
Pageof 41